The recent arrival of Tirzepatide 40mg represents a possibly groundbreaking advancement in the treatment of type 2 the illness. This therapy builds upon the prior success of lower dosages , showing impressive results in reducing blood glucose readings and promoting a decrease in weight. Experts are assessing its full effect on cardiovascular health